> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# AngioDynamics Paid Retiring CEO Clemmer $6.1 Million As Executive Bonuses Hit 180% Of Target
- URL: https://www.bullished.co/angiodynamics-paid-retiring-ceo-clemmer-6-1-million-as-executive-bonuses-hit-180-of-target-21c4444d/
- Published: 2026-10-08T12:35:54.000Z
- Updated: 2026-10-08T12:35:54.000Z
- Description: The annual proxy shows bonuses at 180% of target, a board shrinking to seven and a request for more equity-plan room.
- Author: Matteo Parrino
- Tags: SEC Filings, ANGO, Industry: Healthcare, Topic: Leadership & Governance

[AngioDynamics](https://www.bullished.co/tag/ango/) paid CEO James C. Clemmer [$6,060,145](https://www.sec.gov/Archives/edgar/data/0001275187/000114036126039022/ny20083274x1%5Fdef14a.htm?ref=bullished.co) in total compensation for the fiscal year ended May 31, 2026, including a $1,502,490 cash bonus, according to the annual proxy filed Thursday. Every named executive got an annual bonus at 180% of target, and shareholders are being asked to approve more shares for the equity plan.

## What the proxy says about pay

The bonus formula had two financial metrics and four corporate goals. Net sales came in at $320.2 million against a $312 million target, and adjusted EBITDA was $18.2 million against a $10.5 million target. Each metric scored 200% of target, the plan's maximum. The committee scored the corporate objectives at 100%.

Those objectives were manufacturing-transfer milestones, a private/payer reimbursement plan for NanoKnife, milestones in the Ambition/BTK plan and clarity on a pathway for AngioVac endocarditis. The combined payout was 180%.

The proxy lists the bonuses paid: Clemmer $1,502,490, CFO Stephen A. Trowbridge $598,537, Lawrence T. Weiss $478,332, Laura Piccinini $500,422 and Warren G. Nighan $454,313\. Clemmer's base salary rose 3.0% to $834,717\. His long-term equity target was 400% of base salary, the highest of the named executives; Trowbridge's was 315% and the other three were at 120%.

The committee said the roughly 93.1% support for last year's pay vote showed strong backing, so it left its approach unchanged in fiscal 2026.

## Equity plan and board changes

Shareholders will vote on amending the 2020 Equity Incentive Plan. As of May 31, 2026, 2,610,868 shares remained available to issue, while outstanding awards under the plan covered 4,843,386 securities. Those are 1,435,596 options, 1,947,894 restricted stock units and 1,459,896 performance share units.

Board Chairman Howard W. Donnelly, a director since 2004, will retire from the chair at the annual meeting. The board is expected to shrink from eight directors to seven. Shareholders will also elect Class II directors Eileen O. Auen and Jan Stern Reed to terms running to 2029.

The proxy still lists Clemmer as a Class I director with a term to 2028\. [MarketWatch reported](https://www.marketwatch.com/story/angiodynamics-names-eric-honroth-president-ceo-as-james-clemmer-retires-ce8b21c5?ref=bullished.co) that Clemmer is retiring and Eric Honroth will succeed him on Nov. 2, with Clemmer staying on as a consultant.

## How the votes work

The pay vote is advisory and non-binding on the board. The equity plan amendment needs a majority of shares represented and entitled to vote, and abstentions count as no votes on it. Brokers cannot vote uninstructed shares on the plan, the pay vote or director elections. The company will file an 8-K with final results within four business days of the meeting.

Honroth's Nov. 2 start, per MarketWatch, is the next dated event, with the annual meeting votes to follow.

### Sources

- [AngioDynamics — DEF 14A (2026-10-08)](https://www.sec.gov/Archives/edgar/data/0001275187/000114036126039022/ny20083274x1%5Fdef14a.htm?ref=bullished.co) — SEC EDGAR
- [AngioDynamics: Fiscal Q1 Earnings Snapshot – WTOP News](https://wtop.com/national/2026/10/angiodynamics-fiscal-q1-earnings-snapshot/?ref=bullished.co) — wtop.com
- [AngioDynamics Names Eric Honroth President, CEO as James Clemmer Retires](https://www.marketwatch.com/story/angiodynamics-names-eric-honroth-president-ceo-as-james-clemmer-retires-ce8b21c5?ref=bullished.co) — MarketWatch
- [AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence – Company Announcement - FT.com](https://markets.ft.com/data/announce/detail?dockey=600-202610020600BIZWIRE%5FUSPRX%5F%5F%5F%5F20261002%5FBW607160-1&ref=bullished.co) — Financial Times
- [AngioDynamics Affirms FY2027 Adj EPS Guidance...](https://www.benzinga.com/news/26/10/62239329/angiodynamics-affirms-fy2027-adj-eps-guidance-0-29-0-24-vs-0-27-est-affirms-fy2027-sales-guidance-33?ref=bullished.co) — benzinga.com
- [Angiodynamics, Inc. v. Biolitec, Inc.](https://www.law360.com/cases/4dde823c1d1d2e4233000001?ref=bullished.co) — law360.com

### More on AngioDynamics

- [AngioDynamics Cuts Quarterly Loss To $7.1 Million, Names Eric Honroth CEO And Holds Guidance](https://www.bullished.co/angiodynamics-cuts-quarterly-loss-to-7-1-million-names-eric-honroth-ceo-and-holds-guidance-779e3a53/)
- [AngioDynamics' Incoming CEO Gets $735,000 Salary, 95% Bonus Target And $350,000 Sign-On Cash](https://www.bullished.co/angiodynamics-incoming-ceo-gets-735-000-salary-95-bonus-target-and-350-000-sign-on-cash-a4fe261d/)

[All AngioDynamics (ANGO) coverage →](https://www.bullished.co/tag/ango/)